Maelstrom Research Staging | MIReCoV_LTCH_staff_2_to_4_weeks_postdose

MIReCoV_LTCH_staff_2_to_4_weeks_postdose_2

Networks -

Variables -

Associated study MIReCoV Contingency Table

Population

MIReCoV - LTCH staff

The population is composed of individuals over the age of 18 who are working in long-term care homes (LTCH) and are receiving the mRNA1273 or BNT162b2 COVID-19 vaccine.

Selection Criteria

Minimum age

Newborns

Twins

Countries

Canada

Territory

Ethnic Origin

Health Status

Participants are excluded if they have a PCR confirmed COVID-19 infection.

Other Criteria

Participants are the working staff of long-term care homes.

Individuals are excluded if they received their second COVID-19 vaccine dose over six weeks before enrollment or if they are not interested in receiving a COVID-19 vaccine.

Recruitment

Sources of recruitment

Specific population

Specific Population

Members of an association

Supplementary Information

Staff are recruited from one of twelve participating long-term care homes. The staff are invited by phone to participate if they did not opt-out of further communication about the study.

Number of Participants

Number of Participants: 125
Number of Participants with Biological Samples: 125
Supplementary Information about selection criteria

More info

Data Collection Event

MIReCoV - LTCH staff - 2 to 4 weeks post-dose 2

Saliva samples were collected.

More info

Collected Dataset / MIReCoV_LTCH_staff_2_to_4_weeks_postdose_2

MIReCoV_LTCH_staff_2_to_4_weeks_postdose_2

Population

MIReCoV - LTCH staff

Data Collection Event

MIReCoV - LTCH staff - 2 to 4 weeks post-dose 2

Files

Variables Classifications